Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

and PHILADELPHIA, July 6, 2020 /PRNewswire/ -- Unum Therapeutics Inc.("Unum") (NASDAQ: UMRX), a biopharmaceutical company focused on developing therapies for solid tumors, today announced it has completed the acquisition of Kiq LLC ("Kiq"), a privately held, biotechnology company focused on the discovery and development of precision kinase inhibitors.